Harmony Biosciences Holdings, Inc. (HRMY): Shareholders' Equity
$870.22M
As of 2025-12-31
$999.24M
As of 2026-06-30
+29.3%
3-year compound annual growth
+55.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $870.22M | +32.0% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $659.15M | +41.1% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $466.99M | +15.9% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $402.84M | +116.0% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $186.51M | +91.9% | 2024-02-22, Balance as of period end |
| 2020-12-31 | $97.18M | n/m | 2023-02-21, Balance as of period end |
| 2019-12-31 | -$422.86M | n/a | 2022-02-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $870.22M | +32.0% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $540.72M | +33.9% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $503.42M | +163.5% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $489.09M | -16.9% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $602.69M | -20.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $301.68M | +31.8% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $647.80M | -4.7% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $522.60M | +8.2% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $693.11M | -11.0% |
Compare HRMY, ANIP, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗